Drimva

Verily

Senior Biostatistician

$130K–$196K

Dallas, Texas +3 · Hybrid · Senior · Full-time · Posted Oct 8, 2026

Location
Dallas, Texas
Boston - 100 Causeway
Raleigh - 1101 Haynes
San Bruno - 999 Bayhill
Experience
5+ years.
Education
Master’s degree or higher in biostatistics, statistics, epidemiology, data science, bioinformatics, biomedical informatics, or a related quantitative field.
Visa sponsorship
Qualified applicants must not require employer sponsored work authorization now or in the future for employment in the United States.

About the job

Leads statistical study design and analysis across the product lifecycle to generate and communicate evidence for health products and decisions.

What you'll do

  • Designs and analyzes studies from feasibility through validation and post-market monitoring.
  • Translates scientific and product questions into study objectives, analysis plans, and decision criteria with cross-functional teams.
  • Assesses data quality, bias, missingness, generalizability, and model performance, and communicates findings and limitations.

What they ask for

  • Master’s degree or higher in a quantitative field listed in the posting or a related field.
  • 5+ years applying statistical methods in clinical, biomedical, health technology, or related research.
  • Expertise designing and analyzing observational, interventional clinical, and real-world data studies.
  • Experience programming in R and/or Python to analyze complex life science, biomedical, or healthcare datasets.

Nice to have

  • Experience with health-regulated products, diverse healthcare data, or digital health and AI/ML-enabled clinical products.
  • Experience with Bayesian methods, adaptive trial designs, causal inference, reproducible workflows, Git, or AI-assisted development tools.

Pay

$130,000 - $196,000 USD base salary

Tools

R, Python, Git

AI focus

May use AI-assisted development tools where appropriate; preferred experience includes evidence generation for AI/ML-enabled clinical products.

Model-written summary · the original posting is authoritative

First seen Oct 10, 2026 · Last verified Nov 5, 2026 (UTC)